Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
TScan Therapeutics
Biotech
BIO, Seaport, Orna and more—Chutes & Ladders
Top BIO lobbyist swiftly departs after BIOSECURE reversal. Karuna leaders launch new venture after BMS buyout. Orna snags top Kite exec as CMO.
Max Bayer
,
Gabrielle Masson
Apr 12, 2024 8:30am
Takeda welcomes new oncology chief from CRISPR—Chutes & Ladders
Feb 9, 2024 9:30am
Former Arena CEO takes over new RNA biotech—Chutes & Ladders
May 26, 2023 9:30am
TScan adds another $100M to the pot for TCR therapies
Jan 25, 2021 8:20am
Qiagen launches coronavirus T-cell test for immunity research
Dec 7, 2020 11:24am
Qiagen, TScan to develop T-cell immune system test for COVID-19
Nov 11, 2020 11:17am
